Login Create Account

Powerpack

Unlock full stockrow access for only $7.9/month and boost yourself as an investor.

  • Watchlist

    Keep track of companies that you follow and research.

  • 10 Years of Data

    Full access to our data with predictions and indicators that we calculate daily.

  • Screener

    Full access to our screener with tons of custom values and customizable email notifications.

  • XLS Exports

    Excel export of financials and screeners you define and save.

Subscribe now
Screener Weekly Summary

BioLife Solutions, Inc. BLFS

Healthcare  —  Medical Instruments & Supplies
Overview Business Profile Analyst Commentary Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

BioLife Solutions, Inc. (BLFS) Business Profile

Updated before January 2025

Company Overview

BioLife Solutions, Inc. (NASDAQ: BLFS) is a leading provider of bioproduction tools and services designed to enhance the quality and shelf life of biologic materials used in cell and gene therapies, biopharmaceuticals, and other regenerative medicine applications. Founded in 1998 and headquartered in Bothell, Washington, BioLife Solutions has grown into a key player in the life sciences industry. The company is led by CEO Michael Rice, who has been instrumental in driving its strategic growth and innovation. Under his leadership, BioLife has expanded its product portfolio and established itself as a trusted partner for biopharma and biotech companies worldwide.

Core Business Segments

Biopreservation Media Products

BioLife Solutions offers a range of proprietary biopreservation media products designed to optimize the storage and transport of biologic materials. These include:

  • CryoStor®: A cryopreservation solution that minimizes cell damage during freezing and thawing processes.
  • HypoThermosol®: A storage and shipping medium that extends the shelf life of cells and tissues.

Automated Storage and Freezing Systems

The company provides advanced storage and freezing systems to ensure the integrity of biologic materials. Key products include:

  • Stirling Ultracold Freezers: Energy-efficient ultra-low temperature freezers.
  • SciSafe Biostorage Services: Comprehensive storage solutions for biologic materials, including GMP-compliant facilities.

Thawing Systems

BioLife Solutions has developed innovative thawing systems to ensure the safe and efficient recovery of frozen biologics. The ThawSTAR® platform is a leading product in this category, offering automated and standardized thawing processes.

Cell Processing Tools

The company also offers tools and technologies to streamline cell processing workflows. These include:

  • SAVSU® Technologies: Precision thermal shipping containers for cell and gene therapies.
  • Custom Bioprocessing Solutions: Tailored solutions to meet specific customer needs.

Business Model

BioLife Solutions operates a diversified business model that integrates products and services to support the entire lifecycle of biologic materials. The company generates revenue through the sale of its proprietary products, subscription-based storage services, and custom solutions. By focusing on innovation and customer-centric solutions, BioLife has built a recurring revenue stream and established long-term partnerships with leading biopharma and biotech companies.

Strategic Direction

BioLife Solutions is committed to driving growth through innovation and strategic acquisitions. The company aims to expand its product portfolio and enter new markets, particularly in the rapidly growing cell and gene therapy sector. Sustainability is also a key focus, with initiatives to reduce the environmental impact of its products and operations. Future plans include:

  • Developing next-generation biopreservation media.
  • Expanding global storage and logistics capabilities.
  • Exploring new product categories, such as advanced cell processing tools.

Competitive Landscape

BioLife Solutions operates in a competitive market, facing challenges from both established players and emerging startups. Key competitors include:

  • Thermo Fisher Scientific: A global leader in life sciences tools and services.
  • GE Healthcare: Known for its bioprocessing and cell therapy solutions.
  • Brooks Life Sciences: Specializes in automated storage and sample management systems.
  • Cryoport: Focused on temperature-controlled logistics for cell and gene therapies.

Despite the competition, BioLife Solutions differentiates itself through its proprietary technologies, customer-centric approach, and commitment to quality.

Risk Factors

While BioLife Solutions has a strong market position, it faces several risks, including:

  • Market Dependence: Reliance on the cell and gene therapy market, which is still in its early stages of growth.
  • Supply Chain Disruptions: Potential delays or shortages in raw materials and components.
  • Regulatory Challenges: Compliance with stringent regulatory requirements in different markets.
  • Economic Uncertainty: Fluctuations in global economic conditions that could impact customer spending.

Recent Developments

BioLife Solutions has made significant strides in recent years, including:

  • Acquisitions: The acquisition of Stirling Ultracold and SciSafe has strengthened its position in the storage and logistics market.
  • Product Innovations: Launch of new biopreservation media and thawing systems.
  • Global Expansion: Establishing new facilities and partnerships to support international growth.
  • COVID-19 Impact: The pandemic highlighted the importance of reliable biopreservation and logistics solutions, boosting demand for BioLife’s products.

Investment Considerations

Strengths

  • Strong market position in the cell and gene therapy sector.
  • Diversified product portfolio and recurring revenue streams.
  • Proven track record of innovation and strategic acquisitions.
  • Experienced leadership team.

Risks

  • Dependence on a niche market with evolving regulatory requirements.
  • Exposure to supply chain disruptions and economic volatility.
  • Intense competition from larger players.

Conclusion

BioLife Solutions, Inc. is a dynamic and innovative company at the forefront of the life sciences industry. With a strong product portfolio, strategic growth initiatives, and a commitment to quality, the company is well-positioned to capitalize on the growing demand for biopreservation and cell processing solutions. While it faces certain risks, its strengths and opportunities make it an attractive option for investors seeking exposure to the rapidly evolving cell and gene therapy market.